List of works by Vesna Blazevic

A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A–C subtypes and the ancestor sequence of the F–H subtypes. Preclinical and clinical studies

article

A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine

scientific article published on 27 August 2019

A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles

scientific article published in January 2012

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

scientific article published on 19 August 2010

A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

scientific article published in January 2004

A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses

scientific article published in July 2001

Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice

scientific article published on January 2016

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

scientific article published on 11 December 2012

Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus

scientific article published on 01 October 2019

Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays.

scientific article published on 14 March 2014

Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses

article

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

scientific article

Development and maturation of norovirus antibodies in childhood

scientific article

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.

scientific article published on 12 December 2017

GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model.

scientific article published on 12 January 2007

Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.

scientific article published on 13 May 2014

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition

scientific article published on 22 April 2015

Helper and Cytotoxic T Cell Responses of HIV Type 1-Infected Individuals to Synthetic Peptides of HIV Type 1 Rev

article

High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.

scientific article published on 26 June 2014

Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses

scientific article

His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display.

scientific article published on 10 July 2015

Identification of a First Human Norovirus CD8 T Cell Epitope Restricted to HLA-A0201 Allele

Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.

scientific article

Immune-based approaches for control of HIV infection and viral-induced immunopathogenesis.

scientific article

Immunization with dendritic cells transfected in vivo with HIV-1 plasmid DNA induces HIV-1-specific immune responses

article

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant

scientific article published on 22 January 2019

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection

scientific article

Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine

scientific article published in July 2006

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects

scientific article published in March 2001

Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

scientific article

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential

scientific article published on 21 June 2018

Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens.

scientific article

Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.

scientific article published on 2 May 2016

Multiple consecutive norovirus infections in the first 2 years of life

scientific article

Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children.

scientific article published on 16 March 2011

Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera

scientific article published on 15 November 2018

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.

scientific article published on 18 August 2011

Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007

scientific article published on 14 April 2011

Norovirus vaccine: one step closer.

scientific article published on 9 September 2014

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

scientific article

Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens

scientific article published on 19 September 2018

Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.

scientific article published on 22 June 2011

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice. ⬇️

scientific article

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype

scientific article published on 25 February 2013

Prevalence of norovirus GII-4 antibodies in Finnish children.

scientific article published in March 2011

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue

scientific article published on September 2005

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus

scientific article published on 12 May 2011

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine

scientific article

Rapid and sensitive detection of norovirus antibodies in human serum with a biolayer interferometry biosensor

article published in 2015

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

scientific article published on 07 July 2020

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

scientific article published on 04 September 2016

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

scientific article published on 23 January 2020

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

scientific article published on 14 October 2015

Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.

scientific article published on 13 April 2017

Rotavirus vaccination and infection induce VP6-specific IgA responses

scientific article published on 19 July 2016

Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins.

scientific article published on 12 August 2016

Stable immobilisation of His-tagged proteins on BLI biosensor surface using cobalt

scholarly article by Sanna Auer et al published May 2017 in Sensors and Actuators B

T Cell Responses to Recall Antigens, Alloantigen, and Mitogen of HIV-Infected Patients Receiving Long-Term Combined Antiretroviral Therapy

article

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

scientific article

Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.

scientific article

Paulina is supported by:

About Paulina

Help